T. Rowe Price Associates

T. Rowe Price Associates’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

T. Rowe Price Associates’s Portfolio GEVA Stock Details GEVA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell
2015 Q1	$101M	Buy
2014 Q4	$45.5M	Buy
2014 Q3	$454K	Buy
2014 Q2	$587K	Buy
2014 Q1	$390K	Hold
2013 Q4	$304K	Buy